Skip Navigation

European Heart Journal 1995 16(Supplement H):9-12; doi:10.1093/eurheartj/16.suppl_H.9
Copyright © 1995 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hoberg, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoberg, E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1995 The European Society of Cardiology

The effects of calcium antagonists after PTCA

E. Hoberg

Compass-Reha-Centrum, Rehabilitationseinrichtung für Herz-Kreislauf-und Gefäβerkrankungen Kiel, Germany

Correspondence: Priv.-Doz. Dr. E. Hoberg, Compass-Reha-Centrum, Heikendorfer Weg 9-27, D-24149 Kiel, Germany

Experiments have shown that calcium antagonists can prevent restenosis after coronar angioplasty. The first controlled clinical trials, however, failed to show such a benefit after PCTA: the recurrence rate was not signnificantly influenced by either nifedipine (10 mg q.i.d.) or diltiazem (90 mg t.i.d.). Another trial used a higher dose of diltiazem (mean 329 mg per day) in a larger number of patients, but again the result was negative. in contrast, diltiazem 180 mg per day was reported more recently to significantly reduce restenosis, and high-dose verapamil treatment was similarly successful in a subgroup of patients with stable angina pectoris at the time of primary successful PCTA.

Despite some important limitations of the five monocentre trials, the combined analysis of the results shows that calcium antagonists have a beneficial effect on restenosis rate after PTCA. Whether this effect is limited to heart rate slowing substances and to special subgroups of lesions has to be clarified by further studies in sufficiently large patient populations.

Key Words: Calcium antagonists • coronary angioplasty • restenosis • stable angina pectoris


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Am Coll CardiolHome page
R. S. Schwartz, N. A. Chronos, and R. Virmani
Preclinical restenosis models and drug-eluting stents: Still important, still much to learn
J. Am. Coll. Cardiol., October 6, 2004; 44(7): 1373 - 1385.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.